Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
April 06, 2016 Filed Apr 8, 2016 19:15 UTC SaleCommon Stock 900 $86.56 $77,904.00
Disclosure

SEC source: 0001209191-16-113722 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,514

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $86.56 (range $86.30 to $86.81).

Read SEC document
April 06, 2016 Filed Apr 8, 2016 19:15 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-113722 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 71,830

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC SaleCommon Stock 400 $81.07 $32,428.00
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $81.07 (range $81.00 to $81.13).

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC SaleCommon Stock 600 $80.08 $48,048.00
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $80.08 (range $79.83 to $80.38).

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC SaleCommon Stock 820 $78.90 $64,698.00
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $78.90 (range $78.69 to $79.20).

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC SaleCommon Stock 3,310 $78.31 $259,206.10
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,104

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $78.31 (range $77.69 to $78.66).

Read SEC document
March 30, 2016 Filed Apr 1, 2016 20:03 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-111459 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · derivative · entry 9

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 76,960

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC SaleCommon Stock 200 $84.54 $16,908.00
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $84.54 (range $84.53 to $84.54).

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC SaleCommon Stock 200 $83.33 $16,666.00
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $83.33 (range $83.29 to $83.37).

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC SaleCommon Stock 800 $82.77 $66,216.00
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $82.77 (range $82.28 to $83.25).

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC SaleCommon Stock 900 $81.48 $73,332.00
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $81.48 (range $81.22 to $82.02).

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC SaleCommon Stock 3,030 $80.64 $244,339.20
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $80.64 (range $80.15 to $81.12).

Read SEC document
March 23, 2016 Filed Mar 25, 2016 19:20 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-110591 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · derivative · entry 10

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 82,090

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 200 $82.98 $16,596.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 600 $82.27 $49,362.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $82.27 (range $81.94 to $82.79).

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 300 $81.00 $24,300.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $81.00 (range $80.92 to $81.12).

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 1,197 $79.98 $95,736.06
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,384

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $79.98 (range $79.74 to $80.31).

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 1,533 $79.00 $121,107.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,581

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $79.00 (range $78.73 to $79.45).

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC SaleCommon Stock 1,300 $78.07 $101,491.00
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,114

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $78.07 (range $77.71 to $78.62).

Read SEC document
March 16, 2016 Filed Mar 18, 2016 19:19 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-109439 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 09, 2016 Filed Mar 11, 2016 19:50 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-107767 · doc4.xml · derivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 87,220

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
March 09, 2016 Filed Mar 11, 2016 19:50 UTC SaleCommon Stock 2,300 $85.84 $197,432.00
Disclosure

SEC source: 0001209191-16-107767 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $85.84 (range $85.40 to $86.35).

F5 · balance_after: Reflects a change in the form of ownership resulting from transfers of shares between trusts and Dr. Boger.

Read SEC document
March 09, 2016 Filed Mar 11, 2016 19:50 UTC SaleCommon Stock 2,830 $84.94 $240,380.20
Disclosure

SEC source: 0001209191-16-107767 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,584

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $84.94 (range $84.40 to $85.39).

Read SEC document
March 09, 2016 Filed Mar 11, 2016 19:50 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-107767 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2016 Filed Mar 4, 2016 20:21 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-106010 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,350

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
March 02, 2016 Filed Mar 4, 2016 20:21 UTC SaleCommon Stock 530 $92.50 $49,025.00
Disclosure

SEC source: 0001209191-16-106010 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,295

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $92.50 (range $92.46 to $92.56).

Read SEC document
March 02, 2016 Filed Mar 4, 2016 20:21 UTC SaleCommon Stock 3,900 $91.82 $358,098.00
Disclosure

SEC source: 0001209191-16-106010 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,825

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $91.82 (range $91.38 to $92.36).

Read SEC document
March 02, 2016 Filed Mar 4, 2016 20:21 UTC SaleCommon Stock 700 $91.19 $63,833.00
Disclosure

SEC source: 0001209191-16-106010 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,725

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $91.19 (range $90.38 to $91.35).

F3 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
March 02, 2016 Filed Mar 4, 2016 20:21 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-106010 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,480

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: Fully vested.

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC SaleCommon Stock 1,830 $86.50 $158,295.00
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,295

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $86.50 (range $85.88 to $86.78).

F7 · balance_after: Reflects a change in the form of ownership resulting from a 02/24/2016 distribution of 4,011 shares from a trust to Dr. Boger.

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC SaleCommon Stock 1,700 $85.20 $144,840.00
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 271,125

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $85.20 (range $84.85 to $85.67).

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC SaleCommon Stock 1,400 $84.03 $117,642.00
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 272,825

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $84.03 (range $83.80 to $84.72).

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC SaleCommon Stock 200 $82.90 $16,580.00
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,225

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $82.90 (range $82.62 to $83.18).

Read SEC document
February 24, 2016 Filed Feb 26, 2016 20:39 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-102790 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 274,425

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 17, 2016 Filed Feb 19, 2016 17:08 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-100331 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,610

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
February 17, 2016 Filed Feb 19, 2016 17:08 UTC SaleCommon Stock 1,830 $87.53 $160,179.90
Disclosure

SEC source: 0001209191-16-100331 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $87.53 (range $87.24 to $88.18).

Read SEC document
February 17, 2016 Filed Feb 19, 2016 17:08 UTC SaleCommon Stock 3,000 $86.74 $260,220.00
Disclosure

SEC source: 0001209191-16-100331 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 267,114

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $86.74 (range $86.22 to $87.18).

Read SEC document
February 17, 2016 Filed Feb 19, 2016 17:08 UTC SaleCommon Stock 300 $85.16 $25,548.00
Disclosure

SEC source: 0001209191-16-100331 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,114

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $85.16 (range $84.66 to $85.56).

Read SEC document
February 17, 2016 Filed Feb 19, 2016 17:08 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-100331 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 10, 2016 Filed Feb 12, 2016 20:00 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 5,130 $0.00 Strike: $35.35 $0.00
Disclosure

SEC source: 0001209191-16-097965 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 107,740

Underlying: Common Stock · 5,130 shares

Expires 2016-07-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
February 10, 2016 Filed Feb 12, 2016 20:00 UTC SaleCommon Stock 1,400 $83.34 $116,676.00
Disclosure

SEC source: 0001209191-16-097965 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 265,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $83.34 (range $83.12 to $83.73).

Read SEC document
February 10, 2016 Filed Feb 12, 2016 20:00 UTC SaleCommon Stock 2,400 $82.64 $198,336.00
Disclosure

SEC source: 0001209191-16-097965 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 266,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $82.64(range $82.12 to $83.04).

Read SEC document
February 10, 2016 Filed Feb 12, 2016 20:00 UTC SaleCommon Stock 1,330 $81.65 $108,594.50
Disclosure

SEC source: 0001209191-16-097965 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 269,084

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $81.65 (range $81.05 to $81.92).

Read SEC document
February 10, 2016 Filed Feb 12, 2016 20:00 UTC Exercise / conversionCommon Stock 5,130 $35.35 $181,345.50
Disclosure

SEC source: 0001209191-16-097965 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 270,414

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 03, 2016 Filed Feb 4, 2016 23:51 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 645 $92.80 $59,856.00
Disclosure

SEC source: 0001209191-16-095840 · doc4.xml · nonDerivative · entry 5

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 115,721

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $92.80 (range $92.40 to $93.03).

Read SEC document
February 03, 2016 Filed Feb 4, 2016 23:51 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 700 $91.89 $64,323.00
Disclosure

SEC source: 0001209191-16-095840 · doc4.xml · nonDerivative · entry 4

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 116,366

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $91.89 (range $91.38 to $92.35).

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.